Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ironwood Pharmaceuticals Inc shares valued at $241,736 were purchased by Davis Andrew on Dec 27 ’24. At $4.00 per share, Davis Andrew acquired 60,434 shares.
Also, Davis Andrew sold 5,360 shares, netting a total of over 21,869 in proceeds. Following the sale of shares at $4.08 each, the insider now holds 284,685 shares.
Before that, Emany Sravan Kumar had sold 11,001 shares from its account. In a trade valued at $44,884, the SVP, COO and CFO traded Ironwood Pharmaceuticals Inc shares for $4.08 each. Upon closing the transaction, the insider’s holdings decreased to 11,001 shares, worth approximately $0.65 million.
As published in their initiating research note from Leerink Partners on September 09, 2024, Ironwood Pharmaceuticals Inc [IRWD] has been a Market perform and the price target has been revised to $5. Analysts at CapitalOne downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal weight”‘ outlook in a report released in early August. As of January 17, 2024, Craig Hallum has initiated its “Buy” rating for IRWD. Earlier on December 14, 2023, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for IRWD stock.
Analyzing IRWD Stock Performance
During the last five days, there has been a drop of approximately -43.28%. Over the course of the year, Ironwood Pharmaceuticals Inc shares have dropped approximately -52.37%. Shares of the company reached a 52-week high of $4.78 on 01/07/25 and a 52-week low of $2.05 on 02/05/25. A 50-day SMA is recorded $3.70, while a 200-day SMA reached $5.10. Nevertheless, trading volume fell to 2.68 million shares from 2.58 million shares the previous day.
Support And Resistance Levels for Ironwood Pharmaceuticals Inc (IRWD)
According to the 24-hour chart, there is a support level at 2.04, which, if violated, would cause prices to drop to 1.96. In the upper region, resistance lies at 2.20. The next price resistance is at 2.29. RSI (Relative Strength Index) is 22.94 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.07, which suggests the price will decrease in the coming days. Percent R is at 96.97%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
